Canopy Growth, Tilray Shares Rise After DOJ Proposes Marijuana Reclassification

Dow Jones05-17

By Josh Beckerman

 

Canopy Growth and Tilray Brands shares rose after the Justice Department submitted a proposed regulation to reschedule marijuana under the Controlled Substances Act.

Shares of Canopy Growth were up 17% to $11.60, while Tilray Brands shares were up 7.5% to $3.01 in recent trading.

The DOJ said the proposal emphasizes marijuana's "currently accepted medical use" in the U.S.

Shares of several cannabis companies increased in late April following an Associated Press report that said the U.S. Drug Enforcement Administration may reclassify marijuana to Schedule III from Schedule I.

 

Write to Josh Beckerman at josh.beckerman@wsj.com

 

(END) Dow Jones Newswires

May 16, 2024 13:58 ET (17:58 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment